Approval for twelve new catheters with a 5 mm tip electrode.  The catheters, as modified, will be marketed under the trade name livewire tc(tm) xls(tm) cardiac ablation system.  The system is indicated for: interruption of accessory atrioventricular (av) conduction pathways associated with tachycardia; the treatment of av nodal re-entrant tachycardia (avnrt); or creation of complete av nodal block in patients with difficult to control ventricular response to an atrial arrhythmia.